b-cell activating factor

Preferred Label : b-cell activating factor;

MeSH definition : A tumor necrosis factor superfamily member that plays a role in the regulation of B-LYMPHOCYTE survival. It occurs as a membrane-bound protein that is cleaved to release an biologically active soluble form with specificity to TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; B-CELL ACTIVATION FACTOR RECEPTOR; and B-CELL MATURATION ANTIGEN.;

MeSH synonym : activating factor, b-cell; b-lymphocyte activating factor; cd257 antigen; cd257 antigens; tall 1 protein; tall-1 protein; tnf and apol-related leukocyte expressed ligand 1; tnf superfamily, member 13b; tumor necrosis factor ligand superfamily member 13b; b lymphocyte activating factor; baff ligand; antigens, cd257; B Lymphocyte Stimulator; activating factor, b-lymphocyte; antigen, cd257; thank protein; tnf and apol related leukocyte expressed ligand 1; blys protein; B cell activating factor; TNFSF13B Protein;

Is substance : O;

Details

Origin ID

D053264;

UMLS CUI

C0767393;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- B cell costimulation [GO term]
- B-Cell Activating Factor Measurement [NCIt concept]
- Deoxyribonucleic acid topoisomerase (substance) [SNOMED CT concept]
- Interleukin 1 [LOINC component]
- Interleukin 4 [LOINC component]
- Interleukin-1 [NCIt concept]
- Interleukin-1 (substance) [SNOMED CT concept]
- Interleukin-4 [FMA entity]
- Interleukin-4 (substance) [SNOMED CT concept]
- Protein [NCIt concept]
- Protein [FMA entity]
- Protein [LOINC component]
- Protein [MedDRA LLT]
- Protein (substance) [SNOMED CT concept]
- Protein C [MedDRA Preferred Term]
- Protein Info [NCIt concept]
- Protein S [MedDRA Preferred Term]
- Protein name [EDAM data]
- Recombinant Interleukin-1 [NCIt concept]
- TNF superfamily member 13b [HGNC gene]
- TNFSF13B Gene [NCIt concept]
- TNFSF13B wt Allele [NCIt concept]
- Tumor necrosis factor ligand superfamily, member 13b [OMIM gene]
- dietary proteins [MedlinePlus Topic]
- g protein [SNOMED Notion]
- interleukin-4 [SNOMED Notion]
- obsolete protein [GO term]
- protein [EDAM format]
- protein [OBI concept]
- protein [Radlex concept]
- protein c [ATC Code]
- protein c, nos [SNOMED Notion]
- protein s, nos [SNOMED Notion]
- protein, nos [SNOMED Notion]
- proteins [IUPAC Term]
Currated CISMeF NLP mapping
- Tumor Necrosis Factor Ligand Superfamily Member 13B [NCIt concept]
Indexing information
- AMG623 peptibody [MeSH Supplementary Concept]
- tabalumab [MeSH Supplementary Concept]
Record concept(s)
- B-Cell activating factor [MeSH concept]
Related MeSH Supplementary Concept(s)
- TNFSF13B protein, Xenopus [MeSH Supplementary Concept]
- TNFSF13B protein, human [MeSH Supplementary Concept]
- Tnfsf13b protein, mouse [MeSH Supplementary Concept]
- rGel-BLyS fusion toxin [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- tabalumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients